Joanne Hama

Array ( [id] => 9812040 [patent_doc_number] => 20150023985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'COMBINATION PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH RESPIRATORY DISEASE OR CONDITION' [patent_app_type] => utility [patent_app_number] => 14/328792 [patent_app_country] => US [patent_app_date] => 2014-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10544 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14328792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9812036 [patent_doc_number] => 20150023980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'COMBINATION PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING AND PREVENTING THE INFECTIOUS DISEASES' [patent_app_type] => utility [patent_app_number] => 14/325455 [patent_app_country] => US [patent_app_date] => 2014-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23926 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14325455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9812029 [patent_doc_number] => 20150023972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'COMBINATION PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING AND PREVENTING THE INFECTIOUS DISEASES' [patent_app_type] => utility [patent_app_number] => 14/324575 [patent_app_country] => US [patent_app_date] => 2014-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23943 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9641924 [patent_doc_number] => 20140220033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'Administration of an Anti-Activin-A Compound to a Subject' [patent_app_type] => utility [patent_app_number] => 14/171670 [patent_app_country] => US [patent_app_date] => 2014-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 50677 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14171670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11066220 [patent_doc_number] => 20160263184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-15 [patent_title] => 'METHODS OF CONTROLLING VASCULARITY USING RAVER2 AS A MEDIATOR FOR EXPRESSION OF VEGF RECEPTOR SFIT1' [patent_app_type] => utility [patent_app_number] => 14/765226 [patent_app_country] => US [patent_app_date] => 2014-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11592 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14765226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10452017 [patent_doc_number] => 20150337031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'BIOMARKER METHODS AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/654211 [patent_app_country] => US [patent_app_date] => 2013-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13243 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670536 [patent_doc_number] => 20140234399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'HIV VACCINE' [patent_app_type] => utility [patent_app_number] => 14/132267 [patent_app_country] => US [patent_app_date] => 2013-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 19326 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14132267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10422594 [patent_doc_number] => 20150307606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'LYOPHILIZED SPHERICAL PELLETS OF ANTI-IL-23 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/650605 [patent_app_country] => US [patent_app_date] => 2013-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11203 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14650605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10905256 [patent_doc_number] => 20140308269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'HUMANIZED ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/083146 [patent_app_country] => US [patent_app_date] => 2013-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17645 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14083146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12212121 [patent_doc_number] => 09908916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-06 [patent_title] => 'Peptide for suppressing osteoclast differentiation and use thereof' [patent_app_type] => utility [patent_app_number] => 14/906829 [patent_app_country] => US [patent_app_date] => 2013-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 6806 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14906829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10425157 [patent_doc_number] => 20150310168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'METHOD FOR PREDICTING GENE CLUSTER INCLUDING SECONDARY METABOLISM-RELATED GENES, PREDICTION PROGRAM, AND PREDICTION DEVICE' [patent_app_type] => utility [patent_app_number] => 14/427349 [patent_app_country] => US [patent_app_date] => 2013-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10417 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11647987 [patent_doc_number] => 20170143889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-25 [patent_title] => 'IMMOBILIZED TUMOR NECROSIS FACTOR-ALPHA MUTEINS FOR ENHANCING IMMUNE RESPONSE IN MAMMALS' [patent_app_type] => utility [patent_app_number] => 13/957577 [patent_app_country] => US [patent_app_date] => 2013-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11279 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13957577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10256334 [patent_doc_number] => 20150141332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'METHODS FOR DIAGNOSING OSTEOARTHRITIS' [patent_app_type] => utility [patent_app_number] => 14/405726 [patent_app_country] => US [patent_app_date] => 2013-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7588 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14405726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10450724 [patent_doc_number] => 20150335738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'SECRETORY IMMUNOGLOBULIN DEFICIENCY TREATMENT AND PROPHLAXIS' [patent_app_type] => utility [patent_app_number] => 14/397641 [patent_app_country] => US [patent_app_date] => 2013-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23637 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9901049 [patent_doc_number] => 20150056249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'INFLUENZA VACCINES' [patent_app_type] => utility [patent_app_number] => 14/386096 [patent_app_country] => US [patent_app_date] => 2013-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12583 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14386096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9041143 [patent_doc_number] => 20130243781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'SIGNAL PEPTIDE-CONTAINING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/763102 [patent_app_country] => US [patent_app_date] => 2013-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21820 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13763102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8814179 [patent_doc_number] => 20130115224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha' [patent_app_type] => utility [patent_app_number] => 13/736931 [patent_app_country] => US [patent_app_date] => 2013-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25673 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13736931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9197612 [patent_doc_number] => 20130336927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'CULTURING CIRCULAR ssDNA VIRUSES FOR THE PRODUCTION OF VACCINES' [patent_app_type] => utility [patent_app_number] => 13/726289 [patent_app_country] => US [patent_app_date] => 2012-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13697 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13726289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685904 [patent_doc_number] => 20140242669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'PRODUCTION OF INFECTIOUS RNA VIRUSES IN YEAST' [patent_app_type] => utility [patent_app_number] => 14/239194 [patent_app_country] => US [patent_app_date] => 2012-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4258 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8707559 [patent_doc_number] => 20130064849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'METHODS TO TREAT AND PREVENT CARDIOVASCULAR DISEASE USING HUMAN PAPILLOMAVIRUS VACCINES' [patent_app_type] => utility [patent_app_number] => 13/548854 [patent_app_country] => US [patent_app_date] => 2012-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8211 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13548854 [rel_patent_id] =>[rel_patent_doc_number] =>)